Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | $272.9M | |
| Revenue Growth (YoY) | -- | -- | -- | 90.96% | -9.97% | |
| Cost of Revenues | -- | -- | -- | -- | $277.3M | |
| Gross Profit | -- | -- | -- | -- | -$4.4M | |
| Gross Profit Margin | -- | -- | 3.98% | -0.32% | -1.6% | |
| R&D Expenses | -- | -- | $187.7K | $329.3K | $127.3K | |
| Selling, General & Admin | -- | -- | -- | -- | $22.5M | |
| Other Inc / (Exp) | -- | -- | $117.3K | -$5.9M | -$1.6M | |
| Operating Expenses | -- | -- | -- | -- | $24.9M | |
| Operating Income | -- | -- | -- | -- | -$29.3M | |
| Net Interest Expenses | -- | -- | -- | -- | $5.8M | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -$36.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -$39.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -$39.5M | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -$1.53 | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -$1.53 | |
| Weighted Average Basic Share | -- | -- | -- | -- | $25.8M | |
| Weighted Average Diluted Share | -- | -- | -- | -- | $25.8M | |
| EBITDA | -- | -- | -- | -- | -$28.3M | |
| EBIT | -- | -- | -- | -- | -$31M | |
| Revenue (Reported) | -- | -- | -- | -- | $272.9M | |
| Operating Income (Reported) | -- | -- | -- | -- | -$29.3M | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -$31M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $135.9K | -- | $877.3K | $538.1K | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | $135.9K | $50K | $913.4K | $570.5K | |
| Operating Income | -- | -$135.9K | -$50K | -$913.4K | -$570.5K | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$140.1K | -$232.8K | -$702.9K | $115.5K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $45.3K | $139.6K | |
| Net Income to Company | -- | -$140.1K | -$232.8K | -$748.1K | -$24K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -$140.1K | -$232.8K | -$748.1K | -$24K | |
| Basic EPS (Cont. Ops) | -- | -$0.01 | -$0.01 | -$0.09 | -$0.00 | |
| Diluted EPS (Cont. Ops) | -- | -$0.01 | -$0.01 | -$0.09 | -$0.00 | |
| Weighted Average Basic Share | -- | $25.6M | $25.6M | $8.6M | $8.2M | |
| Weighted Average Diluted Share | -- | $25.6M | $25.6M | $8.6M | $8.2M | |
| EBITDA | -- | -$135.9K | -$50K | -$913.4K | -$570.5K | |
| EBIT | -- | -$135.9K | -$50K | -$913.4K | -$570.5K | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -$135.9K | -$50K | -$913.4K | -$570.5K | |
| Operating Income (Adjusted) | -- | -$135.9K | -$50K | -$913.4K | -$570.5K | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $135.9K | $355.2K | $1.7M | $2.5M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | $605.9K | $1.9M | $2.7M | |
| Operating Income | -- | -- | -$605.9K | -$1.9M | -$2.7M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -$140.1K | -$891K | $999.5K | $325.8K | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | $523K | $589.6K | |
| Net Income to Company | -- | -- | -$891K | $476.5K | -$263.9K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -$891K | $476.5K | -$263.9K | |
| Basic EPS (Cont. Ops) | -- | -- | -$0.03 | $0.04 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -- | -$0.01 | -$0.03 | $0.04 | -$0.02 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -- | -- | -$605.9K | -$1.9M | -$2.7M | |
| EBIT | -- | -- | -$605.9K | -$1.9M | -$2.7M | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -$605.9K | -$1.9M | -$2.7M | |
| Operating Income (Adjusted) | -- | -- | -$605.9K | -$1.9M | -$2.7M | |
| Period Ending | 2022-02-13 | 2023-02-13 | 2024-02-13 | 2025-02-13 | ||
|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | -- | -- | -- | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | -- | -- | -- | -- | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | -- | -- | -- | |
| Net Income to Company | -- | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -- | -- | -- | -- | -- | |
| Basic EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Diluted EPS (Cont. Ops) | -- | -- | -- | -- | -- | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | -- | -- | -- | |
| Revenue (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | -- | -- | -- | |
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $710.5K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | $17.6M | $25.2M | $17.9M | |
| Inventory | -- | -- | -- | -- | $19.4M | |
| Prepaid Expenses | -- | -- | -- | -- | $915.5K | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | -- | -- | $51.1M | |
| Property Plant And Equipment | -- | -- | -- | -- | $48.9M | |
| Long-Term Investments | -- | -- | -- | -- | $4.4M | |
| Goodwill | -- | -- | $2M | -- | $650K | |
| Other Intangibles | -- | -- | $440.5K | $2.2M | $1.8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | $107.4M | |
| Accounts Payable | -- | -- | -- | -- | $39.6M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | $555.3K | $17.4M | $23M | |
| Current Portion Of Capital Lease Obligations | -- | -- | $1.3M | $1.5M | $1.8M | |
| Other Current Liabilities | -- | -- | $6.9M | $3.1M | $3.4M | |
| Total Current Liabilities | -- | -- | -- | -- | $114.8M | |
| Long-Term Debt | -- | -- | -- | -- | $138.9K | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $141.9M | |
| Common Stock | -- | -- | -- | -- | $580 | |
| Other Common Equity Adj | -- | -- | -- | $35.8K | $125.1K | |
| Common Equity | -- | -- | -- | -- | -$34.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -$34.5M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $107.4M | |
| Cash and Short Terms | -- | -- | -- | -- | $710.5K | |
| Total Debt | -- | -- | -- | -- | $59.1M | |
| Period Ending | 2020-07-31 | 2021-07-31 | 2022-07-31 | 2023-07-31 | 2024-07-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | -- | -- | $479.7K | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | -- | -- | -- | -- | $8.1M | |
| Inventory | -- | -- | -- | -- | $6.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | $1.1M | |
| Total Current Assets | -- | -- | -- | -- | $27.9M | |
| Property Plant And Equipment | -- | -- | -- | -- | $46M | |
| Long-Term Investments | -- | -- | -- | -- | $3.9M | |
| Goodwill | -- | -- | -- | -- | $633K | |
| Other Intangibles | -- | -- | -- | -- | $2M | |
| Other Long-Term Assets | -- | -- | -- | -- | $666.6K | |
| Total Assets | -- | -- | -- | -- | $81.1M | |
| Accounts Payable | -- | -- | -- | -- | $37.4M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | $23.3M | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | $1.7M | |
| Other Current Liabilities | -- | -- | -- | -- | $19.2M | |
| Total Current Liabilities | -- | -- | -- | -- | $120.1M | |
| Long-Term Debt | -- | -- | -- | -- | $18.5M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | $164.3M | |
| Common Stock | -- | -- | -- | -- | $17.9M | |
| Other Common Equity Adj | -- | -- | -- | -- | $245.9K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -$83.2M | |
| Total Liabilities and Equity | -- | -- | -- | -- | $81.1M | |
| Cash and Short Terms | -- | -- | -- | -- | $479.7K | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-01-31 | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -$39.5M | |
| Depreciation & Amoritzation | -- | -- | $1.1M | $2.3M | $2.7M | |
| Stock-Based Compensation | -- | -- | -- | $5.3M | $2.3M | |
| Change in Accounts Receivable | -- | -- | -$7.8M | -$6.6M | $7.3M | |
| Change in Inventories | -- | -- | -$20.8M | $4.2M | $16.2M | |
| Cash From Operations | -- | -- | -- | -- | $5.3M | |
| Capital Expenditures | -- | -- | -- | -- | $2.7M | |
| Cash Acquisitions | -- | -- | -- | -- | -$1.2M | |
| Cash From Investing | -- | -- | -- | -- | -$3.3M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $24M | $19.9M | $9.7M | |
| Long-Term Debt Repaid | -- | -- | -$1.2M | -$1.7M | -$11M | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -$1.2M | $852.2K | -$1.6M | |
| Cash From Financing | -- | -- | -- | -- | -$3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | $1.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -$1M | |
| Ending Cash (CF) | -- | -- | -- | -- | $705.3K | |
| Levered Free Cash Flow | -- | -- | -- | -- | $2.6M | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -$140.1K | -$232.8K | -$748.1K | -$24K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -$789.8K | -$384.3K | -$272.2K | -$589.2K | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -$200M | -- | -$299.9K | $5.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | $201M | $335K | $525K | -$5.1M | |
| Beginning Cash (CF) | -- | $243.6K | $40.1K | $39.4K | $4.3K | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | $210.7K | -$49.3K | -$47.1K | $3.3K | |
| Ending Cash (CF) | -- | $454.3K | -$9.2K | -$7.7K | $7.6K | |
| Levered Free Cash Flow | -- | -$789.8K | -$384.3K | -$272.2K | -$589.2K | |
| Period Ending | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -$891K | $476.5K | -$263.9K | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -$538.5K | -$866.9K | -$1.7M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | $171.8M | $6.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | $335K | -$171M | -$4.9M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$203.5K | -$700 | -$35.1K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -$538.6K | -$866.9K | -$1.7M | |
| Period Ending | 2022-02-13 | 2023-02-13 | 2024-02-13 | 2025-02-13 | ||
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
Signup to receive the latest stock alerts
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Though certainly less well-known than the huge tech businesses that…
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Market Cap: $4.6T
P/E Ratio: 65x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 29x
Teradata Corp. [TDC] is down 11.64% over the past day.
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.